MEP of the week

Lobby organisation

MEDICINES FOR EUROPE

Business group · Health & pharma · HQ: Belgium · Transparency Register entry

As of 7 November 2026, MEDICINES FOR EUROPE appears in 107 declared MEP meetings (47 different MEPs), most often with European People's Party.

107
declared meetings
with current MEPs
47
MEPs met
€500k/yr
declared lobbying spend
self-reported to the register
8.0
lobbyists
full time equivalent

In their own words

“Medicines for Europe represents the pharmaceutical companies supplying the largest share of medicines across Europe and is the voice of the generic, biosimilar and value added medicines industries. As a leading partner for better healthcare, we aim to increase the health and wellbeing of all Europeans through better access to high quality medicines.”

Read the rest of the statementShow less of the statement

“Medicines for Europe members’ portfolio cover 80% of therapy areas, and in so doing, safeguards the sustainability of Europe’s healthcare systems for future generations.”

Stated goals from the organisation's own Transparency Register filing.

Who they meet, and when

Which groups they meet

Share of this organisation's 107 declared meetings, by the meeting MEP's political group.

European People's Party3634%
Socialists & Democrats3129%
Patriots for Europe1211%
European Conservatives & Reformists98%
Renew Europe98%
Greens/EFA87%
Non-attached11%
The Left11%

Meetings by year

Declared meetings per calendar year, 2019–2026. Bar length is relative to its busiest year (39 in 2025). Hatched: 2026 is a part-year - the record runs to 6 Nov 2026.

2019
2
2020
2
2021
2
2022
3
2023
18
2024
6
2025
39
2026
35

Group is each MEP's current political group, not necessarily the one they sat with at the time. Shares are rounded to whole percent.

The MEPs they meet most

Tiemo Wölken
12 meetings · S&D
Nicolás González Casares
10 meetings · S&D
Dolors Montserrat
7 meetings · EPP
Tilly Metz
5 meetings · Greens/EFA
Tomislav Sokol
5 meetings · EPP

The 15 most recent declared meetings

DateMEPSubject
22 Oct 2026Aurelijus VerygaEuropean Biotech Act and the Generic and Biosimilar Medicines Sector
21 Oct 2026Ondřej KnotekBiotech Act
23 Sep 2026Nicolás González CasaresBiosimilar pharmaceutical policy
3 Jul 2026Tiemo WölkenBiotech Act
3 Jul 2026Nicolás González CasaresBiotech
2 Jul 2026András Tivadar KuljaBiotech Act
2 Jul 2026Christophe GrudlerPolitique industrielle européenne
1 Jul 2026Aurelijus VerygaBiosimilar Medicines, Access to Healthcare and EU Biotech Competitiveness
1 Jul 2026Ville NiinistöInnovation policy
1 Jul 2026Viktória FerencExchange of views on Biotech Act
24 Jun 2026Emil RadevEuropean Biotech Act
24 Jun 2026Lukas MandlBiotech Act I
24 Jun 2026Ton DiepeveenCompetitiveness of the Biotech Sector
23 Jun 2026Mario FuroreBiotech act
18 Jun 2026Billy KelleherUWWTD and BioTech Act

Meeting an MEP is a normal part of democratic life; the record is shown so anyone can see it.